Stockreport

EyePoint Pharmaceuticals (EYPT): Valuation Update Following Positive Phase 3 DURAVYU Safety Review [Yahoo! Finance]

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF This marks a key step in ongoing clinical progress. See our latest analysis for EyePoint Pharmaceuticals. With the successful safety milestone for DURAVYU front and [Read more]